164 related articles for article (PubMed ID: 21670959)
1. Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.
Piao D; Jiang T; Liu G; Wang B; Xu J; Zhu A
Mol Biol Rep; 2012 Jan; 39(1):661-8. PubMed ID: 21670959
[TBL] [Abstract][Full Text] [Related]
2. Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator.
King JA; Ofori-Acquah SF; Stevens T; Al-Mehdi AB; Fodstad O; Jiang WG
Breast Cancer Res; 2004; 6(5):R478-87. PubMed ID: 15318930
[TBL] [Abstract][Full Text] [Related]
3. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
4. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Taniguchi T; Yokoi K; Osada H; Sekido Y
J Surg Res; 2013 Jan; 179(1):24-32. PubMed ID: 22985775
[TBL] [Abstract][Full Text] [Related]
5. Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis.
Davies SR; Dent C; Watkins G; King JA; Mokbel K; Jiang WG
Oncol Rep; 2008 Feb; 19(2):555-61. PubMed ID: 18202807
[TBL] [Abstract][Full Text] [Related]
6. Activated Leukocyte Cell Adhesion Molecule (ALCAM) is associated with suppression of breast cancer cells invasion.
Jezierska A; Olszewski WP; Pietruszkiewicz J; Olszewski W; Matysiak W; Motyl T
Med Sci Monit; 2006 Jul; 12(7):BR245-56. PubMed ID: 16810131
[TBL] [Abstract][Full Text] [Related]
7. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
Darvishi B; Boroumandieh S; Majidzadeh-A K; Salehi M; Jafari F; Farahmand L
Exp Mol Pathol; 2020 Aug; 115():104443. PubMed ID: 32380056
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.
Burkhardt M; Mayordomo E; Winzer KJ; Fritzsche F; Gansukh T; Pahl S; Weichert W; Denkert C; Guski H; Dietel M; Kristiansen G
J Clin Pathol; 2006 Apr; 59(4):403-9. PubMed ID: 16484444
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer.
King JA; Tan F; Mbeunkui F; Chambers Z; Cantrell S; Chen H; Alvarez D; Shevde LA; Ofori-Acquah SF
Mol Cancer; 2010 Oct; 9():266. PubMed ID: 20929568
[TBL] [Abstract][Full Text] [Related]
10. Activated leukocyte cell adhesion molecule is a marker for thyroid carcinoma aggressiveness and disease-free survival.
Chaker S; Kak I; MacMillan C; Ralhan R; Walfish PG
Thyroid; 2013 Feb; 23(2):201-8. PubMed ID: 23148625
[TBL] [Abstract][Full Text] [Related]
11. [Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy].
Kilic E; Milde-Langosch K; Müller V; Wirtz R; Ihnen M
Pathologe; 2008 Nov; 29 Suppl 2():347-52. PubMed ID: 18810438
[TBL] [Abstract][Full Text] [Related]
12. A novel molecular magnetic resonance imaging agent targeting activated leukocyte cell adhesion molecule as demonstrated in mouse brain metastasis models.
Zarghami N; Soto MS; Perez-Balderas F; Khrapitchev AA; Karali CS; Johanssen VA; Ansorge O; Larkin JR; Sibson NR
J Cereb Blood Flow Metab; 2021 Jul; 41(7):1592-1607. PubMed ID: 33153376
[TBL] [Abstract][Full Text] [Related]
13. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
Liang S; Huang C; Jia S; Wang B
Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
[TBL] [Abstract][Full Text] [Related]
14. Activated leukocyte cell adhesion molecule expression predicts lymph node metastasis in oral squamous cell carcinoma.
van den Brand M; Takes RP; Blokpoel-deRuyter M; Slootweg PJ; van Kempen LC
Oral Oncol; 2010 May; 46(5):393-8. PubMed ID: 20371201
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.
Jeong YJ; Oh HK; Park SH; Bong JG
Molecules; 2018 Jan; 23(1):. PubMed ID: 29315254
[TBL] [Abstract][Full Text] [Related]
17. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival.
Weichert W; Knösel T; Bellach J; Dietel M; Kristiansen G
J Clin Pathol; 2004 Nov; 57(11):1160-4. PubMed ID: 15509676
[TBL] [Abstract][Full Text] [Related]
18. Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential 'Seed' and 'Soil' Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers.
Yang YM; Ye L; Ruge F; Fang Z; Ji K; Sanders AJ; Jia S; Hao C; Dou QP; Ji J; Jiang WG
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614319
[TBL] [Abstract][Full Text] [Related]
19. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A; Matysiak W; Motyl T
Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
[TBL] [Abstract][Full Text] [Related]
20. MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma.
Verma A; Shukla NK; Deo SV; Gupta SD; Ralhan R
Oncology; 2005; 68(4-6):462-70. PubMed ID: 16024937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
